Press release
Psoriasis Drugs Market Size - Forecasts to 2026
Psoriasis Drugs Market
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Psoriasis Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/psoriasis-drugs-market-3419
By Treatment Type (Topicals, Systemic, Biologics), By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors, Anti-Inflammatory, Corticosteroids, Vitamin D Analogues), By Application (Plaque Psoriasis, Guttate Psoriasis, Nail Psoriasis, Erythrodermic Psoriasis, Pustular Psoriasis, Intertriginous Psoriasis, Others), By Distribution Channel (Hospitals & Clinics, E-commerce, Retail Pharmacies), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• Owing to technological breakthroughs, personalized medicine is rapidly gaining momentum in the market as an important element of value-based medication that strives to improve the quality of treatment.
• Biologic-based medications are foreseen to predominate because it provides patients with superior symptom supervision and management, as well as an enhanced quality of living.
• The market for tumor necrosis factor inhibitors is estimated to predominate owing to the potential to mitigate inflammation.
• The market for nail psoriasis is estimated to predominate because of the condition's elevated incidence rate.
• Systemic medications and phototherapy aids in the supremacy of the hospitals & clinics segment.
• High therapeutic enactment and the involvement of key manufacturing companies aids in the predominance of the North American region.
• UCB, Novartis AG, Merck, Johnson & Johnson, Eli Lilly & Company, Celgene Corporation, Boehringer Ingelheim, AstraZeneca, Amgen Inc, AbbVie Inc., Pfizer Inc., Janssen Biotech Inc, Stiefel Laboratories Inc, and Takeda Pharmaceutical Company Limited, among others, are the key players in the market.
Browse the Report @ https://www.globalmarketestimates.com/market-report/psoriasis-drugs-market-3419
Treatment Type Outlook (Revenue, USD Billion, 2021-2026)
• Topicals
• Systemic
• Biologics
Therapeutic Class Outlook (Revenue, USD Billion, 2021-2026)
• Tumor Necrosis Factor Inhibitor
• Interleukin Inhibitors
• Anti-Inflammatory
• Corticosteroids
• Vitamin D Analogues
Application Outlook (Revenue, USD Billion, 2021-2026)
• Plaque Psoriasis
• Guttate Psoriasi
• Nail Psoriasis
• Erythrodermic Psoriasis
• Pustular Psoriasis
• Intertriginous psoriasis
• Others
Distribution Channel Outlook (Revenue, USD Billion, 2021-2026)
• Hospitals and Clinics
• E-commerce
• Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA
Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Drugs Market Size - Forecasts to 2026 here
News-ID: 2339201 • Views: …
More Releases from Global Market Estimates Research & Consultants
Global Market Estimates Hosts Exclusive Webinar on Future Trends in Quick Commer …
Gain Strategic Insights and a Comprehensive Report on August 1st
Global Market Estimates (GME) is excited to announce an exclusive webinar, "Future Trends in the Global Quick Commerce Market: Forecasts to 2029," scheduled for August 1, 2024, at 11am EST. This insightful session will feature Mr. Yash Jain, Director - Global Accounts & Strategic Advisory.
For a registration fee of USD 499, attendees will receive a comprehensive report valued at USD 5,450,…
Global Flare Monitoring Market Size & Trends
According to a new market research report published by Global Market Estimates, the global flare monitoring market is expected to grow at a CAGR of 6.5% from 2024 to 2029.
Global flare monitoring market growth is driven by factors such as safety and risk management and growing emphasis on reduction of emissions.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market Insights
• As per…
Global Fiber Optic Component System Market Size & Trends
According to a new market research report published by Global Market Estimates, the global fiber optic component system market is expected to grow at a CAGR of 8.46 % from 2024 to 2029.
Global fiber optic component system market growth is driven by factors such as growing demand for safety regulations and technological developments.
Unlock the Executive Summary of the report at only USD 249. Book a call now: https://tidycal.com/yashsushiljain/unlock-strategic-insights-press-release
Key Market…
Global Rechargeable Battery Market Size & Trends
According to a new market research report published by Global Market Estimates, the global rechargeable battery market is expected to grow at a CAGR of 15.4% from 2024 to 2029.
Rechargeable batteries have been growing in popularity due to their inherent superiority over disposable batteries in environmental pollution. As rechargeable batteries can be recharged after every use, they cause much lower environmental degradation as compared to disposable batteries, which are discarded…
More Releases for Psoriasi
Psoriasis Patient Pool Analysis Market Forecast to Reach USD 32.5 Billion by 203 …
Psoriasis is a chronic, immune-mediated skin condition characterized by red, scaly plaques that significantly affect patients' physical and emotional well-being. Beyond the skin, psoriasis is linked to systemic comorbidities such as psoriatic arthritis, cardiovascular disease, and depression. With millions affected globally, psoriasis remains a major public health issue.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71525
The psoriasis patient pool is steadily expanding due to rising diagnosis rates, better awareness…
Generalized Pustular Psoriasis (GPP) Market is expected to reach USD 3.1 billion …
Generalized pustular psoriasis (GPP) is a rare, severe, and potentially life-threatening form of psoriasis characterized by widespread sterile pustules, systemic inflammation, and recurrent flares. Unlike plaque psoriasis, GPP can cause acute episodes that require emergency care, making it a critical unmet need in dermatology.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71539
Until recently, treatment options for GPP were limited to off-label use of systemic therapies and immunosuppressants. However, the…
Phototherapies for Psoriasis Market Set to Witness Significant Growth by 2025-20 …
Introduction
Psoriasis is a chronic autoimmune skin condition characterized by rapid skin cell turnover, leading to scaling, inflammation, and plaques. Affecting millions globally, psoriasis is not only a dermatological concern but also a systemic disorder linked to comorbidities such as arthritis, cardiovascular disease, and metabolic syndrome.
Phototherapy has long been an established treatment option for moderate-to-severe psoriasis, leveraging controlled ultraviolet (UV) light to slow skin cell growth and reduce inflammation. Recent advancements…
Chronic Plaque Psoriasis Market is expected to double, reaching USD 36 billion b …
Chronic plaque psoriasis is the most common form of psoriasis, accounting for nearly 80-90% of all cases worldwide. It is a chronic autoimmune disease characterized by raised, inflamed, and scaly skin patches that significantly affect patients' quality of life. While topical therapies and phototherapy have long been standard treatments, the advent of biologics and targeted small molecules has transformed the market.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71377
With…
Generalized Pustular Psoriasis (GPP) Market Emerging Trends and Growth Prospects …
Introduction
Generalized pustular psoriasis (GPP) is a rare, severe, and potentially life-threatening form of psoriasis characterized by widespread pustules, systemic inflammation, and recurrent flares. Unlike plaque psoriasis, GPP is less common but often far more severe, requiring urgent treatment and long-term disease management.
With increasing awareness, advances in biologics, and the emergence of targeted therapies specifically developed for GPP, the global market is entering a transformative phase. Over the next decade, pharmaceutical…
Moderate to Severe Psoriasis Market Growth, Trends, Consumer Demand and Key Oppo …
Introduction
Psoriasis is a chronic, immune-mediated skin disorder marked by red, scaly plaques that can cause significant physical discomfort and psychological burden. Among the different types, moderate to severe psoriasis requires systemic therapy or biologics due to its extensive nature and comorbidities, such as psoriatic arthritis, cardiovascular disease, and metabolic syndrome.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71343
Historically, management involved topical corticosteroids, phototherapy, and systemic drugs like methotrexate or…
